 |
|
 |
| |
 |
|
Class Information
Number: 514/530
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Ester doai > Z-c(=o)-o-y wherein z is hydrogen or an organic radical bonded to the c(=o) by a carbon and y is an organic radical bonded to the oxygen by a carbon > Z contains a cyclopentyl or cyclopentene ring
Description: Subject matter wherein the Z is or contains a cyclopentyl or cyclopentene moiety.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7585895 |
Therapeutic substituted cyclopentanes |
Sep. 8, 2009 |
| 7498360 |
Method and compositions for local treatment of Meniere's disease, tinnitus and/or hearing loss |
Mar. 3, 2009 |
| 7452556 |
Compositions for the treatment of pilosebaceous gland inflammations comprising aluminum fluoride |
Nov. 18, 2008 |
| 7407987 |
Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
Aug. 5, 2008 |
| 7388029 |
Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
Jun. 17, 2008 |
| 7365097 |
Use of at least one (dihydro)jasmonic acid derivative as a desquamating agent |
Apr. 29, 2008 |
| RE39609 |
8-iso-prostaglandins for glaucoma therapy |
May. 1, 2007 |
| 7202275 |
Malonamic acids and derivatives thereof as thyroid receptor ligands |
Apr. 10, 2007 |
| 7176238 |
Nitrostated and nitrosylated prostaglandins, compositions and methods of use |
Feb. 13, 2007 |
| 7163959 |
Prostagladin derivatives for the treatment of glaucoma or ocular hypertension |
Jan. 16, 2007 |
| 7141607 |
Methods and compositions for treating and inhibiting retinal neovascularization |
Nov. 28, 2006 |
| 7141606 |
Gabapentin analogues for sleep disorders |
Nov. 28, 2006 |
| 7129272 |
Apoptosis inhibitor |
Oct. 31, 2006 |
| 7084178 |
Antiamyloid phenylsulfonamides: N-cycloalkylcarboxamides derivatives |
Aug. 1, 2006 |
| 7074827 |
Method for treating ocular hypertension and glaucoma |
Jul. 11, 2006 |
| 7053119 |
Methods for identifying and using IKK inhibitors |
May. 30, 2006 |
| 7049340 |
Neuroprotective and retinoprotective ophthalmologic drugs |
May. 23, 2006 |
| 7019031 |
Anticancer agents based on regulation of protein prenylation |
Mar. 28, 2006 |
| 6981684 |
Post support apparatus with rotatable post guide |
Jan. 3, 2006 |
| 6982283 |
Method for treating drug-induced constipation |
Jan. 3, 2006 |
| 6972294 |
Compounds, their preparation and use |
Dec. 6, 2005 |
| 6958146 |
Compounds to affect insect behavior and to enhance insecticides |
Oct. 25, 2005 |
| 6956057 |
EP4 agonists as agents for lowering intraocular pressure |
Oct. 18, 2005 |
| 6956056 |
Method for providing a cathartic effect |
Oct. 18, 2005 |
| 6933289 |
Inhibition of irritating side effects associated with use of a topical ophthalmic medication |
Aug. 23, 2005 |
| 6921774 |
Compounds and their use as glycine transport inhibitors |
Jul. 26, 2005 |
| 6884819 |
Neuropathy remedies |
Apr. 26, 2005 |
| 6875787 |
10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
Apr. 5, 2005 |
| 6858650 |
Stable salts of novel derivatives of 3,3-diphenylpropylamines |
Feb. 22, 2005 |
| 6849649 |
N-phenpropylcyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
Feb. 1, 2005 |
| 6825232 |
Use of hydroxyeicosatetraenoic acid compounds to treat ophthalmic inflammatory disorders |
Nov. 30, 2004 |
| 6780874 |
Enamine derivatives |
Aug. 24, 2004 |
| 6770675 |
Compositions and methods for reducing ocular hypertension |
Aug. 3, 2004 |
| 6767920 |
3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure |
Jul. 27, 2004 |
| 6723748 |
Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension |
Apr. 20, 2004 |
| 6716876 |
Cyclopentane(ENE)heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents |
Apr. 6, 2004 |
| 6713464 |
Derivatives of 3,3-diphenylpropylamines |
Mar. 30, 2004 |
| 6710081 |
Erection insufficiency remedies |
Mar. 23, 2004 |
| 6683071 |
Initiation of oestrus |
Jan. 27, 2004 |
| 6680337 |
Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
Jan. 20, 2004 |
| 6680339 |
15-fluoro prostaglandins as ocular hypotensives |
Jan. 20, 2004 |
| 6673841 |
Alprostadil alkyl ester-containing composition for external application |
Jan. 6, 2004 |
| 6670394 |
Method for treating COPD |
Dec. 30, 2003 |
| 6664290 |
Oral or vaginal administration of mesoprostol in third stage labor |
Dec. 16, 2003 |
| 6660756 |
N-phenpropylcyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
Dec. 9, 2003 |
| 6649654 |
Methods for identifying and using IKK inhibitors |
Nov. 18, 2003 |
| 6649655 |
11.beta.-fluoro 15.beta.-hydroxy PGF2.alpha. analogs as FP receptor antagonists |
Nov. 18, 2003 |
| 6649653 |
15-fluoro prostaglandins as ocular hypotensives |
Nov. 18, 2003 |
| 6646001 |
Use of non-steroidal anti-inflammatory agents in combination with prostaglandin FP receptor agonists to treat glaucoma and ocular hypertension |
Nov. 11, 2003 |
| 6610715 |
Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same |
Aug. 26, 2003 |
|
|
|
 |
|
 |
|
| |
Randomly Featured Patents |
|
